Both circ-SHPRH and its transcripts are highly expressed in normal human brain cells, participating in the inhibition of central nervous system cancers through the ubiquitin-proteasome pathways triggered by SHPRH (88, 89). The gene discussed is SHPRH; the disease is central nervous system cancer.